<DOC>
	<DOCNO>NCT03086759</DOCNO>
	<brief_summary>Osteoarthritis knee prevalent disease . However , therapeutic option patient . Platelet-rich plasma treatment option chronic pain . If proven effective intra-articular use , Platelet-rich plasma may help treatment patient . Goal : Primary objective : To compare effectiveness improve pain function medium-term tolerance ( 12 week ) intra-articular injection Platelet-rich plasma versus intraarticular injection triamcinolone hexacetonide patient symptomatic primary knee osteoarthritis . Secondary objective : To compare medium-term effectiveness intra-articular injection Platelet-rich plasma versus intra-articular injection triamcinolone hexacetonide improve synovial hypertrophy quality life patient . Methods : A prospective randomize control double-blind study three group ( n = 33 ) patient symptomatic osteoarthritis knee receive intra-articular infiltration single moment . Patients allocate one three group : 1 ) Platelet-rich plasma group : patient receive plasma ; 2 ) triamcinolone hexacetonide Group : patient receive 40mg triamcinolone hexacetonide ; And 3 ) Isotonic saline solution group : patient receive isotonic saline solution . The patient evaluate `` blind '' evaluator 4 assessment time 12 week follow-up clinical assessment instrument ( rest movement pain , joint edema , goniometry , clinical improvement scale , quality life questionnaire SF36 ) , functional ( Womac questionnaire , M. Lequesne Functional Knee Index , 6 min walk test , Time go test ) , ultrasound test ( quantitative semiquantitative measurement synovial hypertrophy semiquantitative Power Doppler ) . Statistics : The following statistical test use accord need : Student 's test , Mann-whitney , Pearson 's chi-square test ANOVA repeat measure . A statistical significance 5 % consider .</brief_summary>
	<brief_title>Intra-Articular Platelet Rich Plasm Use Osteoarthritis Knee .</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>primary knee osteoarthritis degree II II Kellgren &amp; Lawrence classification pain duration : three month pain visual analogue scale 4 8cm agree participate sign consent form secondary knee osteoarthritis skin lesion knee intraarticular joint injection previous three month steroid use previous 30 day degree I IV Kellgren &amp; Lawrence classification inflammatory arthritis , gout pseudogout cancer previous surgery knee cardiovascular respiratory disease change functional status pregnancy breastfeed coagulation disturb bacterial infection handicap NSAIDs Platelet anticoagulant previous month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>